Kalaris Therapeutics Inc

NASDAQ: KLRS · Real-Time Price · USD
2.46
0.19 (8.37%)
At close: Aug 15, 2025, 3:55 PM
2.42
-1.43%
After-hours: Aug 15, 2025, 04:10 PM EDT

Kalaris Therapeutics Inc Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q3 2024 Q4 2023
Period Ending Mar 31, 2025 Sep 30, 2024 Dec 31, 2023
Cash & Equivalents
100.97M 1.91M 3.17M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
910K 314K n/a
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
695K n/a n/a
Total Current Assets
102.18M 2.15M 3.33M
Property-Plant & Equipment
n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
910K 314K n/a
Total Assets
103.09M 2.46M 3.33M
Account Payables
2.37M 2.23M 2.36M
Deferred Revenue
n/a n/a n/a
Short-Term Debt
n/a 9.25M n/a
Other Current Liabilities
602K 1.72M 540K
Total Current Liabilities
7.14M 13.77M 3.94M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
32.08M 78.08M 44.41M
Total Long-Term Liabilities
32.08M 78.08M 44.41M
Total Liabilities
39.22M 91.84M 48.35M
Total Debt
n/a 9.25M n/a
Common Stock
2K n/a n/a
Retained Earnings
-126.76M -94.53M -47.39M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
63.87M -89.38M -45.02M
Total Investments
n/a n/a n/a